Search research articles
Contact Us
Filters
Showing results (71-80 of 111) with videos related to
Page
of 12
Sort By:
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland
|
March 30, 2021
The Pulmonary Metastasectomy in Colorectal Cancer cohort study: Analysis of case selection, risk factors and survival in a prospective observational study of 512 patients
Tom Treasure, Vernon Farewell, Fergus Macbeth, et al.
Breast (Edinburgh, Scotland)
|
February 20, 2026
Biomarker recall and understanding among people living with metastatic breast cancer - results from an international patient survey
Eva Schumacher-Wulf, Lesley Fallowfield, Runcie C W Chidebe, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland
|
July 26, 2021
The Pulmonary Metastasectomy in Colorectal Cancer (PulMiCC) burden of care study: Analysis of local treatments for lung metastases and systemic chemotherapy in 220 patients in the PulMiCC cohort
Tom Treasure, Vern Farewell, Fergus Macbeth, et al.
Journal of the National Cancer Institute
|
October 9, 2014
Words matter: distinguishing "personalized medicine" and "biologically personalized therapeutics"
Nathan I Cherny, Elisabeth G E de Vries, Linda Emanuel, et al.
Breast (Edinburgh, Scotland)
|
April 23, 2013
International guidelines for management of metastatic breast cancer (MBC) from the European School of Oncology (ESO)-MBC Task Force: Surveillance, staging, and evaluation of patients with early-stage and metastatic breast cancer
Nancy U Lin, Christoph Thomssen, Fatima Cardoso, et al.
The Lancet. Oncology
|
August 23, 2013
Preference for subcutaneous or intravenous administration of trastuzumab in patients with HER2-positive early breast cancer (PrefHer): an open-label randomised study
Xavier Pivot, Joseph Gligorov, Volkmar Müller, et al.
Health Technology Assessment (Winchester, England)
|
May 15, 2023
Mortality impact, risks, and benefits of general population screening for ovarian cancer: the UKCTOCS randomised controlled trial
Usha Menon, Aleksandra Gentry-Maharaj, Matthew Burnell, et al.
Health Technology Assessment (Winchester, England)
|
October 16, 2023
Insights from UKCTOCS for design, conduct and analyses of large randomised controlled trials
Usha Menon, Aleksandra Gentry-Maharaj, Matthew Burnell, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
September 3, 2015
Pain and analgesic use associated with skeletal-related events in patients with advanced cancer and bone metastases
Roger von Moos, Jean-Jacques Body, Blair Egerdie, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 19, 2021
Preference for the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer (PHranceSCa): A randomised, open-label phase II study
Joyce O'Shaughnessy, Susana Sousa, Josefina Cruz, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 111) with videos related to
Sort By:
Page
of 12
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland
|
March 30, 2021
The Pulmonary Metastasectomy in Colorectal Cancer cohort study: Analysis of case selection, risk factors and survival in a prospective observational study of 512 patients
Tom Treasure, Vernon Farewell, Fergus Macbeth, et al.
Breast (Edinburgh, Scotland)
|
February 20, 2026
Biomarker recall and understanding among people living with metastatic breast cancer - results from an international patient survey
Eva Schumacher-Wulf, Lesley Fallowfield, Runcie C W Chidebe, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland
|
July 26, 2021
The Pulmonary Metastasectomy in Colorectal Cancer (PulMiCC) burden of care study: Analysis of local treatments for lung metastases and systemic chemotherapy in 220 patients in the PulMiCC cohort
Tom Treasure, Vern Farewell, Fergus Macbeth, et al.
Journal of the National Cancer Institute
|
October 9, 2014
Words matter: distinguishing "personalized medicine" and "biologically personalized therapeutics"
Nathan I Cherny, Elisabeth G E de Vries, Linda Emanuel, et al.
Breast (Edinburgh, Scotland)
|
April 23, 2013
International guidelines for management of metastatic breast cancer (MBC) from the European School of Oncology (ESO)-MBC Task Force: Surveillance, staging, and evaluation of patients with early-stage and metastatic breast cancer
Nancy U Lin, Christoph Thomssen, Fatima Cardoso, et al.
The Lancet. Oncology
|
August 23, 2013
Preference for subcutaneous or intravenous administration of trastuzumab in patients with HER2-positive early breast cancer (PrefHer): an open-label randomised study
Xavier Pivot, Joseph Gligorov, Volkmar Müller, et al.
Health Technology Assessment (Winchester, England)
|
May 15, 2023
Mortality impact, risks, and benefits of general population screening for ovarian cancer: the UKCTOCS randomised controlled trial
Usha Menon, Aleksandra Gentry-Maharaj, Matthew Burnell, et al.
Health Technology Assessment (Winchester, England)
|
October 16, 2023
Insights from UKCTOCS for design, conduct and analyses of large randomised controlled trials
Usha Menon, Aleksandra Gentry-Maharaj, Matthew Burnell, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
September 3, 2015
Pain and analgesic use associated with skeletal-related events in patients with advanced cancer and bone metastases
Roger von Moos, Jean-Jacques Body, Blair Egerdie, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 19, 2021
Preference for the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer (PHranceSCa): A randomised, open-label phase II study
Joyce O'Shaughnessy, Susana Sousa, Josefina Cruz, et al.
Page
of 12